Panipenem/betamipron

WikiDoc Resources for Panipenem/betamipron
Articles
Most recent articles on Panipenem/betamipron Most cited articles on Panipenem/betamipron Review articles on Panipenem/betamipron Articles on Panipenem/betamipron in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Panipenem/betamipron Images of Panipenem/betamipron Photos of Panipenem/betamipron Podcasts & MP3s on Panipenem/betamipron Videos on Panipenem/betamipron
Evidence Based Medicine
Cochrane Collaboration on Panipenem/betamipron Bandolier on Panipenem/betamipron TRIP on Panipenem/betamipron
Clinical Trials
Ongoing Trials on Panipenem/betamipron at Clinical Trials.gov Trial results on Panipenem/betamipron Clinical Trials on Panipenem/betamipron at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Panipenem/betamipron NICE Guidance on Panipenem/betamipron NHS PRODIGY Guidance FDA on Panipenem/betamipron CDC on Panipenem/betamipron
Books
Books on Panipenem/betamipron
News
Panipenem/betamipron in the news Be alerted to news on Panipenem/betamipron News trends on Panipenem/betamipron
Commentary
Blogs on Panipenem/betamipron
Definitions
Definitions of Panipenem/betamipron
Patient Resources / Community
Patient resources on Panipenem/betamipron Discussion groups on Panipenem/betamipron Patient Handouts on Panipenem/betamipron Directions to Hospitals Treating Panipenem/betamipron Risk calculators and risk factors for Panipenem/betamipron
Healthcare Provider Resources
Symptoms of Panipenem/betamipron Causes & Risk Factors for Panipenem/betamipron Diagnostic studies for Panipenem/betamipron Treatment of Panipenem/betamipron
Continuing Medical Education (CME)
CME Programs on Panipenem/betamipron
International
Panipenem/betamipron en Espanol Panipenem/betamipron en Francais
Business
Panipenem/betamipron in the Marketplace Patents on Panipenem/betamipron
Experimental / Informatics
List of terms related to Panipenem/betamipron

Panipenem/betamipron is a carbapenem antibiotic marketed by M/s Sankyo Co. of Japan. It was launched in 1993, under the brand name Carbenin.

It is a combination in which panipenem is the carbapenem antibiotic and betamipron is a renal inhibitor and inhibits renal uptake of panipenem and also from nephrotoxicity (pretty much like the imipenem/cilastatin combination)